Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Esperion Therapeutics, Inc. (ESPR) had Cash Flow from Investing Activities of $-0.19M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$80.10M |
|
$-25.20M |
|
$34.57M |
|
$45.53M |
|
$86.69M |
|
$-6.58M |
|
$-18.61M |
|
$-25.20M |
|
$-25.20M |
|
$-25.20M |
|
$-25.20M |
|
$-25.20M |
|
$-25.20M |
|
$-6.58M |
|
$-5.96M |
|
251.35M |
|
251.35M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$459.46M |
|
$0.31M |
|
$3.07M |
|
$462.53M |
|
$300.36M |
|
$250.07M |
|
$470.10M |
|
$770.46M |
|
$-307.93M |
|
$-307.99M |
|
$-307.93M |
|
257.40M |
|
| Cash Flow Statement Financials | |
$-27.72M |
|
|
Cash Flow from Investing Activities |
$-0.19M |
$16.22M |
|
$167.85M |
|
$156.16M |
|
$-11.69M |
|
$2.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.53 |
|
-- |
|
-- |
|
-4.32 |
|
-0.81 |
|
56.84% |
|
-8.22% |
|
-8.22% |
|
-- |
|
-31.45% |
|
-31.45% |
|
$-27.91M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.33 |
|
0.61 |
|
148.70 |
|
8.18% |
|
8.18% |
|
-5.45% |
|
43.54% |
|
$-1.20 |
|
$-0.11 |
|
$-0.11 |
|